These symptoms occur because GLP-1 drugs slow gastric emptying and alter the pace of digestion throughout the intestinal tract
These brand-name medications all contain semaglutide, a glucagon-like peptide-1 (GLP-1) agonist
A pill version of semaglutidethe generic name for Novo Nordisks diabetes drug Ozempic and its weight-loss version Wegovywas approved by the Food and Drug Administration as a type 2 diabetes treatment in 2019, but it has largely flown under the radar
Companies that swiftly identify and respond to these changes will position themselves for success, while those adopting a cautious wait-and-see approach may face declining sales
In January, it launched oral Wegovy, the first weight loss pill approved in the U.S
200,201 Clinicians can support individuals by conducting GMV or shared medical appointments (see below), recommending in-person or virtual participation in weight management groups or peer support groups, and addressing barriers to social engagement, such as isolation or mobility challenges
